Status:
COMPLETED
Cameroon HepB Birth Dose Feasibility Pilot
Lead Sponsor:
Clinton Health Access Initiative Inc.
Collaborating Sponsors:
Cameroon Expanded Program on Immunization
Bill and Melinda Gates Foundation
Conditions:
Hepatitis B
Eligibility:
All Genders
Phase:
NA
Brief Summary
This feasibility assessment is to provide quantitative findings of an intervention integrating immunizations into maternity and newborn care across 15 health facilities in Cameroon.
Detailed Description
In the Cameroon Expanded Program on Immunization (EPI), the birth dose vaccine for oral polio vaccine (OPV-0) and tuberculosis vaccine (BCG), are recommended with a third birth dose vaccine for hepati...
Eligibility Criteria
Inclusion
- Facilities will be those that have both an immunization unit as well as a maternity ward
Exclusion
- Facilities without both units
Key Trial Info
Start Date :
June 10 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT04893616
Start Date
June 10 2021
End Date
December 31 2021
Last Update
July 25 2022
Active Locations (13)
Enter a location and click search to find clinical trials sorted by distance.
1
CMA Dibi
Dibi, Adamaoua Region, Cameroon
2
CMA Mbe
Mbé, Adamawe, Cameroon
3
HD Biyem-Assi
Biyem Assi, Center, Cameroon
4
HD Cite Verte
Cite Verte, Center, Cameroon